Contents of this document
- Volume variance-27 Hundred million yen
- Selling price variance212 Hundred million yen
- Variable cost variance-160 Hundred million yen
- Inventory impact81 Hundred million yen
- Fixed-cost variance-18 Hundred million yen
- Effect of suspending DPE operations62 Hundred million yen
- Exchange rate¥159.2 /US$
- Domestic naphtha¥98,400 /K liter
- Global demand for chloroprene rubber23 10,000 tonnes
- Considering doubling Snecton's capacity and an additional investment of approximately ¥1 billion
- Plan to establish Node Chemical Co., Ltd., a sales agency for the styrene-related business, in April 2027
- Node Chemical is scheduled to assume the manufacturing and sales divisions for styrene monomer, functional resins and sheets in April 2028
- From July 2028 onward, the functional resin manufacturing and sales business of DSPL is scheduled to be transferred to a new Singaporean company
- Snecton revenue target (fiscal year 2028)¥200 100 million or more
- Revenue ratio from AI-related and electric power infrastructure applications (Electronics and Advanced Products, current forecast)25 %
- Net debt-to-equity ratio0.69 x
- ROIC5.6 %
- ROE5.1 %
- Electronics & Advanced ProductsNet Sales561 Hundred million yenYear-on-year change in revenue60 Hundred million yenOperating profit83 Hundred million yenOperating profit year on year20 Hundred million yen
- Life InnovationNet Sales198 Hundred million yenYear-on-year change in revenue-17 Hundred million yenOperating profit22 Hundred million yenOperating profit year on year-17 Hundred million yen
- Elastomers & Infrastructure SolutionsNet Sales481 Hundred million yenYear-on-year change in revenue-17 Hundred million yenOperating profit57 Hundred million yenOperating profit year on year91 Hundred million yen
- Polymer SolutionsNet Sales767 Hundred million yenYear-on-year change in revenue113 Hundred million yenOperating profit72 Hundred million yenOperating profit year on year57 Hundred million yen
- Other and eliminationsNet Sales79 Hundred million yenYear-on-year change in revenue-19 Hundred million yenOperating profit13 Hundred million yenOperating profit year on year-2 Hundred million yen
- -30 Hundred million yenDetailsProduction cuts for acetylene black due to the impact of the situation in the Middle East
- -25 Hundred million yenDetailsFactors expected to reduce profit under the current plan, including the impact on acetylene black and other products in Electronics and Advanced Products
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | 2,087 Hundred million yen (YoY +6.1%) |
| Operating profit | 247 Hundred million yen (YoY +154.6%) |
| Ordinary income | 212 Hundred million yen (YoY +211.8%) |
| Net income | 69 Hundred million yen (YoY +76.9%) |
| Operating profit margin | 11.8 |
| Results for the three months of the current quarter | Net Sales 1,117 Hundred million yen / Operating profit 137 Hundred million yen / Operating income by segment Electronics & Advanced Products 47 / Life Innovation 19 / Elastomers & Infrastructure Solutions 29 / Polymer Solutions 36 / Other and eliminations 6 |
| Full-year earnings forecast | Net Sales 4,250 Hundred million yen / Operating profit 370 Hundred million yen / Ordinary income 260 Hundred million yen / Net income 160 Hundred million yen / Operating profit margin 8.7 % / Annual Dividend ¥100 /share |
| Self-assessment against the plan | Raised from the initial forecast |
| Segment results | Segment Electronics & Advanced Products / Net Sales 561 Hundred million yen / Year-on-year change in revenue 60 Hundred million yen / Operating profit 83 Hundred million yen / Operating profit year on year 20 Hundred million yen, Segment Life Innovation / Net Sales 198 Hundred million yen / Year-on-year change in revenue -17 Hundred million yen / Operating profit 22 Hundred million yen / Operating profit year on year -17 Hundred million yen, Segment Elastomers & Infrastructure Solutions / Net Sales 481 Hundred million yen / Year-on-year change in revenue -17 Hundred million yen / Operating profit 57 Hundred million yen / Operating profit year on year 91 Hundred million yen, Segment Polymer Solutions / Net Sales 767 Hundred million yen / Year-on-year change in revenue 113 Hundred million yen / Operating profit 72 Hundred million yen / Operating profit year on year 57 Hundred million yen, Segment Other and eliminations / Net Sales 79 Hundred million yen / Year-on-year change in revenue -19 Hundred million yen / Operating profit 13 Hundred million yen / Operating profit year on year -2 Hundred million yen |
| Breakdown of Factors Affecting the Change | Factors Volume variance / Amount -27 Hundred million yen, Factors Selling price variance / Amount 212 Hundred million yen, Factors Variable cost variance / Amount -160 Hundred million yen, Factors Inventory impact / Amount 81 Hundred million yen, Factors Fixed-cost variance / Amount -18 Hundred million yen, Factors Effect of suspending DPE operations / Amount 62 Hundred million yen |
| Key KPIs | Indicator name Snecton revenue target (fiscal year 2028) / Value ¥200 100 million or more / Year on year against the same period last year Not disclosed, Indicator name Revenue ratio from AI-related and electric power infrastructure applications (Electronics and Advanced Products, current forecast) / Value 25 % / Year on year against the same period last year Not disclosed, Indicator name Net debt-to-equity ratio / Value 0.69 x / Year on year against the same period last year Not disclosed, Indicator name ROIC / Value 5.6 % / Year on year against the same period last year Not disclosed, Indicator name ROE / Value 5.1 % / Year on year against the same period last year Not disclosed |
| Number of employees | DPE employees: approximately 250 (end-March 2025) → approximately 140 (end-December 2025) → approximately 70 (end-October 2026) → slightly more than 40 planned from January 2027 onward |
| Assumptions Underlying the Business Outlook | Item Exchange rate / Value ¥159.2 /US$, Item Domestic naphtha / Value ¥98,400 /K liter, Item Global demand for chloroprene rubber / Value 23 10,000 tonnes |
| Risk amount incorporated into the outlook | Amount -30 Hundred million yen / Details Production cuts for acetylene black due to the impact of the situation in the Middle East, Amount -25 Hundred million yen / Details Factors expected to reduce profit under the current plan, including the impact on acetylene black and other products in Electronics and Advanced Products |
| Medium-term management plan targets | Plan name Mission2030 Phase 2 / Target fiscal year FY2028 / Operating profit 450 Hundred million yen / ROE 8 % / Comparison with actual results No change to the fiscal 2028 plan |
| Financial targets | ROE Target value 8 % / Current estimate/actual 5.1 % / ROIC Current estimate/actual 5.6 % / Net debt-to-equity ratio Current estimate/actual 0.69 x / DOE Current estimate/actual 2.7 % |
| Annual Dividend | Annual dividend per share ¥100 /share / Interim ¥50 /share / End of period ¥50 /share |
| Payout ratio | 54 |
| Capital expenditures | ¥470 100 million (capital expenditures, investments and loans, current full-year forecast) |
| New initiatives | Considering doubling Snecton's capacity and an additional investment of approximately ¥1 billion, Plan to establish Node Chemical Co., Ltd., a sales agency for the styrene-related business, in April 2027, Node Chemical is scheduled to assume the manufacturing and sales divisions for styrene monomer, functional resins and sheets in April 2028, From July 2028 onward, the functional resin manufacturing and sales business of DSPL is scheduled to be transferred to a new Singaporean company |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher sales of products for AI-related and electric power infrastructure applications, the effect of the DPE operating suspension, and positive inventory effects boosted performance. Meanwhile, sales volumes of rapid antigen diagnostic kits declined as adjustments to in-market inventories from shipments in the previous fiscal year took longer than expected.